Provided by Tiger Trade Technology Pte. Ltd.

Kamada

8.49
+0.25003.03%
Volume:83.64K
Turnover:706.22K
Market Cap:489.72M
PE:22.29
High:8.59
Open:8.32
Low:8.32
Close:8.24
52wk High:9.35
52wk Low:6.50
Shares:57.68M
Float Shares:31.46M
Volume Ratio:3.86
T/O Rate:0.27%
Dividend:0.25
Dividend Rate:2.94%
EPS(TTM):0.3809
EPS(LYR):0.3500
ROE:8.40%
ROA:4.63%
PB:1.82
PE(LYR):24.26

Loading ...

Kamada Lowers Quarterly Dividend to $0.17 a Share; Payable Sept. 17 to Holders of Record Aug. 27

MT Newswires Live
·
Aug 17

Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026

GlobeNewswire
·
Aug 17

TipRanks Analyst Reaffirms Buy on Kamada as Strong 2Q26 Results and New Growth Drivers Support Multi‑Pillar Expansion

TIPRANKS
·
Aug 14

Kamada Ltd. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 12

Kamada's Finance Chief Chaime Orlev to Step Down

MT Newswires Live
·
Aug 12

Kamada CFO to Depart, 2Q Sales Rise

Dow Jones
·
Aug 12

Kamada FY26 H1 Net Income Rises 18.11% to $13.39 Million; Revenue Climbs 12.83% to $100.16 Million

Reuters
·
Aug 12

Kamada Q2 EPS $0.16 Beats $0.12 Estimate, Sales $54.921M Beat $50.657M Estimate

Benzinga Earnings
·
Aug 12

Press Release: Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance

Dow Jones
·
Aug 12

Press Release: Kamada Announces Planned Transition of Chief Financial Officer

Dow Jones
·
Aug 12

Kamada Ltd. Expected to Post Earnings of 11 Cents a Share - Earnings Preview

Reuters
·
Aug 10

Kamada Shareholders Approve Director Slate, Equity Plan Changes and Auditor for 2026

TIPRANKS
·
Aug 06

Kamada Holds Annual Shareholder Meeting

Reuters
·
Aug 06

Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026

GlobeNewswire
·
Aug 05

Benchmark Co. Sticks to Their Buy Rating for Kamada (KMDA)

TIPRANKS
·
Jul 22

Kamada enters $50M sales agreement to supply plasma to biopharmaceutical company

TIPRANKS
·
Jul 20

Press Release: Kamada Announces a Three-year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company Focused on Plasma-derived Therapies

Dow Jones
·
Jul 20

Kamada Showcases New CYTOGAM Data from 2026 ISHLT Meeting, Signaling Potential Uptick in Transplant Use

TIPRANKS
·
Jul 14

Kamada Highlights CYTOGAM® Study Results Presented at the 2026 ISHLT Annual Meeting

GlobeNewswire
·
Jul 13

Kamada gets FDA approval for Rapid Fluorescent Focus Inhibition Test laboratory

TIPRANKS
·
Jun 01